These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39363313)

  • 1. Burden of disease and cost of illness of infants less than 6 months of age hospitalised with respiratory syncytial virus in Denmark - a 10-year national register-based study.
    von Linstow ML; Rudolfsen JH; Olsen J; Skovdal M; Staerke NB
    BMC Infect Dis; 2024 Oct; 24(1):1098. PubMed ID: 39363313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inpatient burden of respiratory syncytial virus (RSV) in Switzerland, 2003 to 2021: an analysis of administrative data.
    Stucki M; Lenzin G; Agyeman PK; Posfay-Barbe KM; Ritz N; Trück J; Fallegger A; Oberle SG; Martyn O; Wieser S
    Euro Surveill; 2024 Sep; 29(39):. PubMed ID: 39328156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare resource utilisation and costs in infants with confirmed respiratory syncytial virus infections: a national population cohort study.
    Han HJ; Ryu D; Kim JY; Jang S; Suh HS
    BMC Infect Dis; 2024 Oct; 24(1):1152. PubMed ID: 39396944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015.
    Jepsen MT; Trebbien R; Emborg HD; Krause TG; Schønning K; Voldstedlund M; Nielsen J; Fischer TK
    Euro Surveill; 2018 Jan; 23(3):. PubMed ID: 29386093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review.
    Bechini A; Salvati C; Bonito B; Del Riccio M; Stancanelli E; Bruschi M; Ionita G; Iamarino JA; Bentivegna D; Buscemi P; Ciardi G; Cosma C; Stacchini L; Conticello C; Bega M; Paoli S; Schirripa A; Bertizzolo L; Muzii B; Azzi MV; Parisi S; Trippi F; Bonanni P; Boccalini S
    Public Health; 2024 Feb; 227():103-111. PubMed ID: 38154422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study.
    Thampi N; Knight BD; Thavorn K; Webster RJ; Lanctot K; Hawken S; McNally JD
    CMAJ Open; 2021; 9(4):E948-E956. PubMed ID: 34667075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya.
    Nyiro JU; Nyawanda BO; Mutunga M; Murunga N; Nokes DJ; Bigogo G; Otieno NA; Lidechi S; Mazoya B; Jit M; Cohen C; Moyes J; Pecenka C; Baral R; Onyango C; Munywoki PK; Vodicka E
    BMC Public Health; 2024 Sep; 24(1):2410. PubMed ID: 39232690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Burden of Medically Attended Respiratory Syncytial Virus Infections Among Privately Insured Children Under 5 Years of Age in the USA.
    Tran PT; Nduaguba SO; Wang Y; Diaby V; Finelli L; Choi Y; Winterstein AG
    Influenza Other Respir Viruses; 2024 Jul; 18(7):e13347. PubMed ID: 38951044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization.
    Buckley BC; Roylance D; Mitchell MP; Patel SM; Cannon HE; Dunn JD
    J Manag Care Pharm; 2010; 16(1):15-22. PubMed ID: 20044843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of respiratory syncytial virus in adults in Germany - a health claims analysis between 2015 and 2018.
    Huebbe B; Mocek A; Manz KC; Vivirito A; Bayer LJ; Norris R; Schiffner-Rohe J; von Eiff C; Lade C
    J Med Econ; 2024; 27(1):1063-1075. PubMed ID: 39105626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RSV hospitalisation and healthcare utilisation in moderately prematurely born infants.
    Shefali-Patel D; Paris MA; Watson F; Peacock JL; Campbell M; Greenough A
    Eur J Pediatr; 2012 Jul; 171(7):1055-61. PubMed ID: 22302458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in Malawi.
    Baral R; Mambule I; Vodicka E; French N; Everett D; Pecenka C; Bar-Zeev N
    J Pediatric Infect Dis Soc; 2020 Dec; 9(6):738-745. PubMed ID: 33347578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study.
    Li Y; Johnson EK; Shi T; Campbell H; Chaves SS; Commaille-Chapus C; Dighero I; James SL; Mahé C; Ooi Y; Paget J; van Pomeren T; Viboud C; Nair H
    Lancet Respir Med; 2021 Feb; 9(2):175-185. PubMed ID: 32971018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review.
    Poshtiban A; Wick M; Bangert M; Damm O
    BMC Infect Dis; 2024 Aug; 24(1):844. PubMed ID: 39164625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
    Ares-Gómez S; Mallah N; Santiago-Pérez MI; Pardo-Seco J; Pérez-Martínez O; Otero-Barrós MT; Suárez-Gaiche N; Kramer R; Jin J; Platero-Alonso L; Alvárez-Gil RM; Ces-Ozores OM; Nartallo-Penas V; Mirás-Carballal S; Piñeiro-Sotelo M; Malvar-Pintos A; González-Pérez JM; Rodríguez-Tenreiro-Sánchez C; Rivero-Calle I; Salas A; Durán-Parrondo C; Martinón-Torres F;
    Lancet Infect Dis; 2024 Aug; 24(8):817-828. PubMed ID: 38701823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area.
    Deshpande SA; Northern V
    Arch Dis Child; 2003 Dec; 88(12):1065-9. PubMed ID: 14670770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
    Zhang S; Akmar LZ; Bailey F; Rath BA; Alchikh M; Schweiger B; Lucero MG; Nillos LT; Kyaw MH; Kieffer A; Tong S; Campbell H; Beutels P; Nair H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S680-S687. PubMed ID: 32227101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Wang X; Li Y; Shi T; Bont LJ; Chu HY; Zar HJ; Wahi-Singh B; Ma Y; Cong B; Sharland E; Riley RD; Deng J; Figueras-Aloy J; Heikkinen T; Jones MH; Liese JG; Markić J; Mejias A; Nunes MC; Resch B; Satav A; Yeo KT; Simões EAF; Nair H; ;
    Lancet; 2024 Mar; 403(10433):1241-1253. PubMed ID: 38367641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.